The Heidelberg cardio-oncology unit (COUNT)—a possible blueprint for improved care of cardio-oncological patients

por Lehmann, L. H., Stein, F., Jäger, D., Frey, N.
Publicado 2021

Correlations of palatal surface area with anthropometric dimensions of the head and face

por Assy, Z., Jager, D. H. J., Brand, H. S., Bikker, F. J.
Publicado 2022

Salivary film thickness and MUC5B levels at various intra-oral surfaces

por Assy, Z., Jager, D. H. J., Brand, H. S., Bikker, F. J.
Publicado 2022

Intratumoural injection of the toll-like receptor-2/6 agonist ‘macrophage-activating lipopeptide-2’ in patients with pancreatic carcinoma: a phase I/II trial

por Schmidt, J, Welsch, T, Jäger, D, Mühlradt, P F, Büchler, M W, Märten, A
Publicado 2007

Regional differences in perceived oral dryness as determined with a newly developed questionnaire, the Regional Oral Dryness Inventory

por Assy, Zainab, Jager, D. H. J., Mashhour, E., Bikker, F. J., Brand, H. S.
Publicado 2020

Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma

por Karakhanova, S, Ryschich, E, Mosl, B, Harig, S, Jäger, D, Schmidt, J, Hartwig, W, Werner, J, Bazhin, A V
Publicado 2015

Transforming Growth Factor-β2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling

por van't Land, B, Meijer, H P, Frerichs, J, Koetsier, M, Jager, D, Smeets, R L, M'Rabet, L, Hoijer, M
Publicado 2002

Multimarker RT–PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients

por Nissan, A, Jager, D, Roystacher, M, Prus, D, Peretz, T, Eisenberg, I, Freund, H R, Scanlan, M, Ritter, G, Old, L J, Mitrani-Rosenbaum, S
Publicado 2006

FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies

por Dendl, K., Finck, R., Giesel, F. L., Kratochwil, C., Lindner, T., Mier, W., Cardinale, J., Kesch, C., Röhrich, M., Rathke, H., Gampp, H., Ristau, J., Adeberg, S., Jäger, D., Debus, J., Haberkorn, U., Koerber, S. A.
Publicado 2021

Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial

por Heilig, C.E., Horak, P., Kreutzfeldt, S., Teleanu, V., Mock, A., Renner, M., Bhatti, I.A., Hutter, B., Hüllein, J., Fröhlich, M., Uhrig, S., Süße, H., Heiligenthal, L., Ochsenreither, S., Illert, A.L., Vogel, A., Desuki, A., Heinemann, V., Heidegger, S., Bitzer, M., Scheytt, M., Brors, B., Hübschmann, D., Baretton, G., Stenzinger, A., Steindorf, K., Benner, A., Jäger, D., Heining, C., Glimm, H., Fröhling, S., Schlenk, R.F.
Publicado 2021

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy

por Pixberg, C., Zapatka, M., Hlevnjak, M., Benedetto, S., Suppelna, J.P., Heil, J., Smetanay, K., Michel, L., Fremd, C., Körber, V., Rübsam, M., Buschhorn, L., Heublein, S., Schäfgen, B., Golatta, M., Gomez, C., von Au, A., Wallwiener, M., Wolf, S., Dikow, N., Schaaf, C., Gutjahr, E., Allgäuer, M., Stenzinger, A., Pfütze, K., Kirsten, R., Hübschmann, D., Sinn, H.-P., Jäger, D., Trumpp, A., Schlenk, R., Höfer, T., Thewes, V., Schneeweiss, A., Lichter, P.
Publicado 2022